Nifty
Sensex
:
:
12968.95
44149.72
-18.05 (-0.14%)
-110.02 (-0.25%)

Pharmaceuticals & Drugs - API

Rating :
66/99  (View)

BSE: 532815 | NSE: SMSPHARMA

88.35
1.60 (1.84%)
27-Nov-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  87.10
  •  89.00
  •  86.75
  •  86.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  166607
  •  147.20
  •  101.70
  •  24.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 748.75
  • 23.39
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 891.39
  • 0.28%
  • 2.04

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.29%
  • 2.21%
  • 27.11%
  • FII
  • DII
  • Others
  • 0.3%
  • 0.00%
  • 3.09%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.02
  • -7.60
  • -3.95

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.51
  • -2.15
  • -3.03

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.57
  • -4.72
  • -6.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 18.19
  • 16.90

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.92
  • 2.14
  • 1.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.10
  • 8.91
  • 7.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
130
118
10%
113
117
-4%
96
104
-7%
80
101
-21%
Expenses
106
96
11%
91
94
-2%
82
88
-7%
60
76
-20%
EBITDA
24
22
7%
21
23
-8%
14
16
-8%
20
26
-22%
EBIDTM
18%
19%
19%
20%
14%
14%
25%
25%
Other Income
1
1
59%
1
1
25%
3
1
312%
1
1
34%
Interest
3
3
-9%
3
3
-14%
3
3
-10%
3
3
8%
Depreciation
6
5
4%
5
5
4%
6
5
23%
5
5
11%
PBT
16
14
13%
14
15
-10%
9
8
4%
12
19
-33%
Tax
5
5
3%
5
6
-21%
2
2
28%
5
6
-22%
PAT
11
10
18%
9
9
-3%
6
6
-3%
8
12
-38%
PATM
9%
8%
8%
8%
7%
7%
9%
12%
EPS
1.33
1.13
18%
1.09
1.12
-3%
0.74
0.76
-3%
0.89
1.44
-38%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
420
412
465
465
445
612
200
Net Sales Growth
-5%
-11%
0%
4%
-27%
206%
 
Cost Of Goods Sold
4,840
246
293
290
296
385
110
Gross Profit
-4,420
166
172
175
150
226
90
GP Margin
-1,052%
40%
37%
38%
34%
37%
45%
Total Expenditure
340
332
375
372
370
522
150
Power & Fuel Cost
-
19
22
23
18
34
9
% Of Sales
-
5%
5%
5%
4%
6%
4%
Employee Cost
-
39
36
33
27
38
6
% Of Sales
-
10%
8%
7%
6%
6%
3%
Manufacturing Exp.
-
15
13
12
10
38
7
% Of Sales
-
4%
3%
3%
2%
6%
4%
General & Admin Exp.
-
8
9
8
9
11
3
% Of Sales
-
2%
2%
2%
2%
2%
2%
Selling & Distn. Exp.
-
4
2
5
10
16
10
% Of Sales
-
1%
0%
1%
2%
3%
5%
Miscellaneous Exp.
-
1
0
1
0
1
5
% Of Sales
-
0%
0%
0%
0%
0%
2%
EBITDA
80
80
90
93
75
89
49
EBITDA Margin
19%
19%
19%
20%
17%
15%
25%
Other Income
6
5
3
2
1
4
3
Interest
11
12
12
15
16
17
8
Depreciation
22
22
19
20
19
19
5
PBT
51
51
62
60
42
56
40
Tax
17
18
21
20
6
15
14
Tax Rate
33%
36%
34%
33%
14%
26%
36%
PAT
34
33
41
40
36
42
25
PAT before Minority Interest
34
33
41
40
36
42
25
Minority Interest
0
0
0
0
0
0
0
PAT Margin
8%
8%
9%
9%
8%
7%
13%
PAT Growth
-9%
-21%
2%
14%
-14%
63%
 
EPS
4.04
3.86
4.89
4.78
4.20
4.92
3.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
348
322
284
255
294
192
Share Capital
8
8
8
8
8
10
Total Reserves
340
313
276
246
285
182
Non-Current Liabilities
114
94
97
91
162
88
Secured Loans
67
61
70
73
110
66
Unsecured Loans
1
1
1
1
4
7
Long Term Provisions
2
2
2
1
3
0
Current Liabilities
154
156
134
156
200
49
Trade Payables
44
48
39
67
84
24
Other Current Liabilities
39
23
23
20
40
0
Short Term Borrowings
61
71
58
60
73
0
Short Term Provisions
10
14
14
10
3
25
Total Liabilities
617
572
515
502
656
329
Net Block
280
281
279
290
370
69
Gross Block
361
340
318
310
501
96
Accumulated Depreciation
80
58
39
19
130
27
Non Current Assets
389
351
334
336
408
84
Capital Work in Progress
42
18
8
8
13
15
Non Current Investment
26
27
28
29
21
0
Long Term Loans & Adv.
38
23
16
7
4
0
Other Non Current Assets
2
2
2
2
0
0
Current Assets
228
221
181
166
248
234
Current Investments
0
0
0
0
0
0
Inventories
129
136
107
93
113
50
Sundry Debtors
49
26
24
21
61
60
Cash & Bank
10
15
13
12
15
96
Other Current Assets
40
27
22
28
59
29
Short Term Loans & Adv.
19
17
15
12
23
27
Net Current Assets
74
65
47
10
47
185
Total Assets
617
572
515
502
656
329

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
40
50
32
73
61
14
PBT
51
62
60
42
56
40
Adjustment
29
27
31
32
28
18
Changes in Working Capital
-28
-26
-48
9
-1
-30
Cash after chg. in Working capital
52
63
43
83
83
28
Interest Paid
0
0
0
0
0
0
Tax Paid
-12
-13
-11
-9
-22
-6
Other Direct Exp. Paid
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
Cash From Investing Activity
-43
-35
-17
-39
-97
-32
Net Fixed Assets
-45
-31
-9
128
-346
Net Investments
0
0
-8
-16
-18
Others
2
-3
1
-152
268
Cash from Financing Activity
-2
-13
-15
-33
44
107
Net Cash Inflow / Outflow
-5
2
0
1
9
89
Opening Cash & Equivalents
15
13
12
11
2
7
Closing Cash & Equivalent
10
15
13
12
11
96

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
41
38
34
30
35
18
ROA
6%
8%
8%
6%
8%
8%
ROE
10%
14%
15%
13%
18%
14%
ROCE
13%
17%
18%
13%
20%
19%
Fixed Asset Turnover
1.29
1.53
1.59
1.12
2.11
2.24
Receivable days
30
18
17
33
35
102
Inventory Days
107
89
73
82
47
84
Payable days
47
40
47
72
37
57
Cash Conversion Cycle
91
67
43
44
45
128
Total Debt/Equity
0.44
0.45
0.51
0.59
0.70
0.40
Interest Cover
5
6
5
4
4
6

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.